Publications by authors named "Robin M Joyce"

Claim this Profile
H
High CD34-positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft-versus-host disease or mortality.
Zachary M Avigan, Ajoy L Dias, Laura E Dodge, Jon E Arnason, Robin M Joyce

Transfusion· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of whole-genome and immunoglobulin-based circulating tumor DNA assays in diffuse large B-cell lymphoma.
Reid W Merryman, Justin Rhoades, Kan Xiong, Robert A Redd, Katherine Antel, Robin M Joyce

Hemasphere· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation.
Reid W Merryman, Robert A Redd, Eleanor Taranto, Gulrayz Ahmed, Erin Jeter, Robin M Joyce

Blood Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of minimal residual disease among patients with classical Hodgkin lymphoma undergoing autologous stem cell transplantation.
Eleanor Taranto, Robert Redd, Erin Jeter, Kristin McHugh, Jennifer L Crombie, Robin M Joyce

Leuk Lymphoma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Reconstitution following High-Dose Chemotherapy and Autologous Stem Cell Transplantation with or without Pembrolizumab Maintenance Therapy in Patients with Lymphoma.
Reid W Merryman, Robert Redd, Erin Jeter, Jeff L Wong, Kristin McHugh, Robin M Joyce

Transplant Cell Ther· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma.
Reid W Merryman, Luca Castagna, Laura Giordano, Vincent T Ho, Paolo Corradini, Robin M Joyce

Leukemia· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open notes sounds great, but will a provider's documentation change? An exploratory study of the effect of open notes on oncology documentation.
Maryam Rahimian, Jeremy L Warner, Liz Salmi, S Trent Rosenbloom, Roger B Davis, Robin M Joyce

JAMIA Open· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma.
Reid W Merryman, Robert A Redd, Taiga Nishihori, Julio Chavez, Yago Nieto, Robin M Joyce

Blood Adv· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation.
Matthew J Frigault, Philippe Armand, Robert A Redd, Erin Jeter, Reid W Merryman, Robin M Joyce

Blood Adv· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation.
Philippe Armand, Yi-Bin Chen, Robert A Redd, Robin M Joyce, Jad Bsat

Blood· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significant and Distinctive -Grams in Oncology Notes: A Text-Mining Method to Analyze the Effect of OpenNotes on Clinical Documentation.
Maryam Rahimian, Jeremy L Warner, Sandeep K Jain, Roger B Davis, Jessica A Zerillo, Robin M Joyce

JCO Clin Cancer Inform· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia.
Benjamin L Lampson, Haesook T Kim, Matthew S Davids, Jeremy S Abramson, Arnold S Freedman, Robin M Joyce

Blood Adv· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced-Intensity Conditioning Regimens, Prior Chronic Lymphocytic Leukemia, and Graft-Versus-Host Disease Are Associated with Higher Rates of Skin Cancer after Allogeneic Hematopoietic Stem Cell Transplantation.
Peggy A Wu, Robert S Stern, Victor Huang, Kevin X Liu, Chen Amy Chen, Robin M Joyce

J Invest Dermatol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inherited CHST11/MIR3922 deletion is associated with a novel recessive syndrome presenting with skeletal malformation and malignant lymphoproliferative disease.
Sameer S Chopra, Ignaty Leshchiner, Hatice Duzkale, Heather McLaughlin, Monica Giovanni, Joyce Fingeroth, Robin M Joyce

Mol Genet Genomic Med· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yttrium-90 ibritumomab tiuxetan followed by rituximab maintenance as treatment for patients with diffuse large B-cell lymphoma are not candidates for autologous stem cell transplant.
Jon E Arnason, Katarina Luptakova, Jacalyn Rosenblatt, Dimitrios Tzachanis, David Avigan, Robin M Joyce

Acta Haematol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary cardiac burkitt lymphoma presenting with abdominal pain.
Dimitrios Tzachanis, Rajan Dewar, Katarina Luptakova, James D Chang, Robin M Joyce

Case Rep Hematol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rifaximin suppresses background intestinal 18F-FDG uptake on PET/CT scans.
Elisa Franquet, Mathew R Palmer, Anne E Gifford, Daryl J Selen, Yih-Chieh S Chen, Robin M Joyce

Nucl Med Commun· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of refractory Guillain-Barré syndrome with alemtuzumab in a patient with chronic lymphocytic leukemia.
Dimitrios Tzachanis, Ayad Hamdan, Erik J Uhlmann, Robin M Joyce

Acta Haematol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 78-year-old man with acute myeloid leukemia (AML) and acute renal failure.
Elliot B Tapper, Katarina Luptakova, Robin M Joyce, Dimitrios Tzachanis

Am J Case Rep· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External phenome analysis enables a rational federated query strategy to detect changing rates of treatment-related complications associated with multiple myeloma.
Jeremy L Warner, Gil Alterovitz, Kelly Bodio, Robin M Joyce

J Am Med Inform Assoc· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells.
Dina Stroopinsky, Jacalyn Rosenblatt, Keisuke Ito, Heidi Mills, Li Yin, Robin M Joyce

Cancer Res· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide enhances anti-myeloma cellular immunity.
Katarina Luptakova, Jacalyn Rosenblatt, Brett Glotzbecker, Heidi Mills, Dina Stroopinsky, Robin M Joyce

Cancer Immunol Immunother· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-2 and regulatory T cells in graft-versus-host disease.
John Koreth, Ken-ichi Matsuoka, Haesook T Kim, Sean M McDonough, Bhavjot Bindra, Robin M Joyce

N Engl J Med· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine.
Jacalyn Rosenblatt, Brett Glotzbecker, Heidi Mills, Baldev Vasir, Dimitrios Tzachanis, Robin M Joyce

J Immunother· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of HIV-negative primary effusion lymphoma treated with bortezomib, pegylated liposomal doxorubicin, and rituximab.
Tanya Siddiqi, Robin M Joyce

Clin Lymphoma Myeloma· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis